Biblio Discovery — Demo Discovery Service

5 hasil untuk "Mingfeng Han"

Menampilkan 1–5 · 2,16 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19

    Yong Gao; Tuantuan Li; Mingfeng Han dkk.

    Journal of Medical Virology · 2020 · Inggris · OpenAlex Scopus

    The role of clinical laboratory data in the differential diagnosis of the severe forms of COVID-19 has not been definitely established. The aim of this study was to look for the warning index in severe COVID-19 patients. We investigated 43 adult patients with COVID-19. The patients were classified…

  2. Artikel Jurnal Teks lengkap

    Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China

    Ruirui Wang; Min Pan; Xiumei Zhang dkk.

    International Journal of Infectious Diseases · 2020 · Inggris · OpenAlex Scopus

    OBJECTIVE: To investigate the epidemiological and clinical features of patients with COVID-19 in Anhui province of China. METHOD: In this descriptive study, we obtained epidemiological, demographic, manifestations, laboratory data and radiological findings of patients confirmed by real-time RT-PCR…

  3. Artikel Jurnal

    Effective treatment of severe COVID-19 patients with tocilizumab

    Xiaoling Xu; Mingfeng Han; Tiantian Li dkk.

    Proceedings of the National Academy of Sciences · 2020 · Inggris · OpenAlex Scopus

    After analyzing the immune characteristics of patients with severe coronavirus disease 2019 (COVID-19), we have identified that pathogenic T cells and inflammatory monocytes with large amount of interleukin 6 secreting may incite the inflammatory storm, which may potentially be curbed through…

  4. Artikel Jurnal Teks lengkap

    Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial

    Wei Tang; Zhujun Cao; Mingfeng Han dkk.

    BMJ · 2020 · Inggris · OpenAlex Scopus

    OBJECTIVE: To assess the efficacy and safety of hydroxychloroquine plus standard of care compared with standard of care alone in adults with coronavirus disease 2019 (covid-19). DESIGN: Multicentre, open label, randomised controlled trial. SETTING: 16 government designated covid-19 treatment…